Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR.
Fabbiani, M., Zaccarelli, M., Latini, A., Sterrantino, G., D'ettorre, G., Grima, P., Mondi, A., Rossetti, B., Borchi, B., Giuliani, M., Antinori, A., De Luca, A., Di Giambenedetto, S., Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen, <<HIV MEDICINE>>, 2015; (Settembre): N/A-N/A. [doi:10.1111/hiv.12313] [http://hdl.handle.net/10807/68426]
Autori: | ||
Titolo: | Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1111/hiv.12313 | |
Data di pubblicazione: | 2015 | |
Abstract: | Despite not being approved in Europe as first-line therapy, the efavirenz (EFV)-containing single tablet regimen (STR) is frequently used in clinical practice in naïve patients but few data are available on this strategy. In our study, we aimed to assess the risk of EFV discontinuation in patients starting antiretroviral therapy with STR vs. nonSTR. | |
Lingua: | Inglese | |
Rivista: | ||
Citazione: | Fabbiani, M., Zaccarelli, M., Latini, A., Sterrantino, G., D'ettorre, G., Grima, P., Mondi, A., Rossetti, B., Borchi, B., Giuliani, M., Antinori, A., De Luca, A., Di Giambenedetto, S., Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen, <<HIV MEDICINE>>, 2015; (Settembre): N/A-N/A. [doi:10.1111/hiv.12313] [http://hdl.handle.net/10807/68426] | |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |